DONNA CANNON: Open Payments
NPI 1306236617 · BLUE MOUNTAIN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 23 payments from 9 companies in 2025. Trend: 2023 $1,034 · 2024 $994 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| Novo Nordisk Inc | 5 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $116 |
| Phathom Pharmaceuticals, Inc. | 1 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: FARXIGA, CAPLYTA, VOQUEZNA, Wegovy, JARDIANCE, Ozempic, AIRSUPRA, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
